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Abstract: A large amount of energy produced by active aerobic metabolism is necessary for the cochlea to maintain  
its function. This makes the cochlea vulnerable to blockade of cochlear blood flow and interruption of the oxygen supply. 
Although certain forms of human idiopathic sudden sensorineural hearing loss reportedly arise from ischemic injury, the 
pathological mechanism of cochlear ischemia-reperfusion injury has not been fully elucidated. Recent animal studies have 
shed light on the mechanisms of cochlear ischemia-reperfusion injury. It will help in the understanding of the pathology  
of cochlear ischemia-reperfusion injury to classify this injury into ischemic injury and reperfusion injury. Excitotoxicity, 
mainly observed during the ischemic period, aggravates the injury of primary auditory neurons. On the other hand,   
oxidative damage induced by hydroxyl radicals and nitric oxide enhances cochlear reperfusion injury. This article briefly 
summarizes the generation mechanisms of cochlear ischemia-reperfusion injury and potential therapeutic targets that 
could be developed for the effective management of this injury type. 
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INTRODUCTION 
  The sole purpose of the circulatory system is transporta-
tion. It performs oxygen and nutrient delivery and metabolic 
by-product removal. The labyrinthine artery is a terminal 
artery for cochlear blood supply. The cochlea is highly de-
pendent on blood and oxygen supply to maintain its function. 
In animal models of cochlear ischemia, the cochlea becomes 
hypoxic or ischemic within one minute after occlusion of the 
labyrinthine artery. 
  It has been proposed that one of the major causes of hu-
man idiopathic sudden sensorineural hearing loss is impaired 
blood flow and oxygen delivery to the cochlea [1]. The aim 
of this review is to provide an overview of recent insights 
regarding the pathogenesis of cochlear ischemia-reperfusion 
injury observed in animal studies. 
CHANGES IN COCHLEAR POTENTIALS AND 
MORPHOLOGIES DURING ISCHEMIA 
  Adenosine triphosphate (ATP), a critical compound in 
cellular energy metabolism, is synthesized in mitochondria 
from adenosine diphosphate (ADP) and inorganic phosphate 
in the presence of oxygen and nicotinamide adenine dinucleo- 
tide (NADH). Interruption of the blood supply causes ATP 
depletion in the cochlea [2]. If this ATP depletion during 
ischemia is severe, it may lead to the compromised function 
of all cochlear cells. Perlman et al. [3] were the first to per-
form an extensive study of functional and histological 
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alterations of the cochlea during and after reversible cochlear 
ischemia in the guinea pig. Because the stria vascularis re-
quires high-level energy supply to maintain endocochlear 
potential (EP) levels, EP rapidly declines immediately after 
the onset of ischemia to reach its lowest level (-30 to -40 
mV). EP is essential to maintain the function of hair cells 
and cochlear afferent neurons, and its decrease results in the 
subsequent decrease of other cochlear potentials, such as 
cochlear microphonic (CM), distortion-product otoacoustic 
emission (DPOAE), and compound action potential (CAP) 
[4]. 
  Generally, interruption of the blood supply causes vari-
ous morphological changes including cellular, mitochondrial, 
and nuclear swelling, swelling of the endoplasmic reticulum, 
clearing of the cytoplasm, bleb formation, and the condensa-
tion of chromatin. However, the tolerance of cochlear cells to 
ischemia is variable among cell types. Dendrites of cochlear 
afferent neurons are one of the components most vulnerable 
to ischemia. The swelling of afferent neurons is observed in 
cases of cochlear ischemia of 5 minutes or longer. Ischemia-
induced morphological changes are also observed in hair 
cells. Approximately 15 and 30 minutes of ischemia causes 
the swelling of outer and inner hair cells, respectively. As the 
ischemic period prolongs, more severe morphological 
changes are observed, such as the swelling of nuclei, bleb 
formation, and rupture of the cell membrane. Several hours 
of ischemia induces disintegration of the organ of Corti [4]. 
EXCITOTOXICITY OF COCHLEAR AFFERENT 
NEURONS DURING THE ISCHEMIC PERIOD 
  Excitotoxicity is an important and well-accepted theory 
proposed by Olney et al. [5], which explains one of the ma-
jor pathophysiologies of brain ischemia. Excitotoxicity is Ischemia-Reperfusion Injury  Current Neuropharmacology, 2010, Vol. 8, No. 2    129 
caused by excessive amounts of glutamate in synaptic cleft. 
Glutamate is a putative excitatory neurotransmitter between 
inner hair cells and afferent neurons [6, 7]. Although vital for 
cochlear function, excessively released glutamate and the 
failure of its removal from synaptic clefts can lead to the 
excitotoxicity of cochlear afferent neurons due to the loss of 
ionic homeostasis. Puel et al. [8] showed that cochlear 
ischemia causes the excitotoxicity of afferent neurons to in-
duce the massive swelling of afferent dendrites. 
  The excessive efflux of glutamate from inner hair cells 
results in cochlear excitotoxicity. Massive glutamate efflux 
in the perilymph of the cochlea is observed during cochlear 
ischemia [9, 10]. Besides this excessive efflux, the failed 
uptake of glutamate from the synaptic clefts into surrounding 
cells also causes cochlear excitotoxicity. To date, five   
subtypes of Na
+-dependent glutamate transporter: GLT-1, 
GLAST,
 EAAC1, EAAT4, and EAAT5, have been cloned 
[11-13]. Previous studies have demonstrated that GLAST is 
present in the supporting cells surrounding inner hair cells 
and in the satellite cells surrounding spiral ganglion neurons 
in the rodent cochlea [14, 15]. Takumi et al. [16] demon-
strated the colocalization of GLAST and glutamine syn-
thetase in supporting cells around inner hair cells. Based on 
their findings, it is suggested that glutamate released from 
the presynaptic region is taken into adjacent supporting cells 
using GLAST and then converted to glutamine in the sup-
porting cells [17]. Glutamate transporters are required to 
terminate glutamate actions. Hakuba et al. [18] has shown 
that GLAST knockout mice are vulnerable to cochlear exci-
totoxicity. Although GLT-1 and EAAC1 also exist in the 
cochlea, the involvement of these glutamate transporters in 
cochlear exctitotoxicity has not yet been clarified. 
  It is now widely accepted that glutamate receptors fall 
into two major classes: the ionotropic receptors formed by 
ligand-gated cation channels and the metabotropic receptors 
that are coupled to G-proteins and act though intracellular 
chemical mechanisms [19-21]. Eight subtypes of me-
tabotropic glutamate receptors have been currently identi-
fied, and subdivided into three groups according to sequence 
homology and response to agonists [22]. Ionotropic gluta-
mate receptors are divided into three types: AMPA, kainite, 
and N-methyl-D-aspartate (NMDA) receptors. The swelling 
of afferent dendrites is induced via non-NMDA ionotropic 
glutamate receptors in the cochlea because the application  
of APMA and kainic acid to the cochlea leads to the same 
swelling of afferent dendrites. An AMPA/kainate receptor   
antagonist, 6-7-dinitroquinoxaline-2,3-dione (DNQX), pro-
tected most of the radial dendrites from the ischemia-induced 
swelling [8]. In contrast to the involvement of AMPA/ 
kainate receptors in the cochlear excitotoxicity and cochlear 
ischemic injury, a definitive role of metabotropic and 
NMDA receptors in cochlear ischemic injury has not been 
shown. MK-801 and D-2-amino-5-phosphonopentanoate, 
NMDA receptor antagonists, did not show protective effects 
against cochlear ischemia [5, 23]. 
  It is now considered that the excitotoxicity of cochlear 
afferent neurons often induces temporary hearing threshold 
shifts [24]. However, Sun et al. [25] demonstrated that some 
cochlear excitotoxicity might induce irreversible cochlear 
lesions because the number of cochlear ganglion neurons 
decreased after exposure to high concentration of kainic   
acid. 
  The swelling of afferent neurons is observed in cases of 
cochlear ischemia of 5 minutes or longer. Excitotoxicity is 
undoubtedly one of the leading causes of cochlear afferent 
neuron injury during ischemia (Fig. 1).  
CHARACTERISTICS OF COCHLEAR INJURY   
DURING THE REPERFUSION PERIOD 
  Although the cochlear response to ischemia has been 
extensively studied, the effects of reperfusion on the cochlea 
have recently received new attention. Recent animal models 
of cochlear ischemic injury are suitable to examine the   
time course of cochlear functions during reperfusion [9, 26-
29]. The CAP threshold representing the function of cochlear 
afferent neurons gradually improved during the reperfusion 
period. On the other hand, DPOAE (representing the func-
tion of outer hair cells) initially recovered with time until 20 
minutes after the onset of reperfusion when the cochlear cir-
culation was restored. Thereafter the amplitude of DPOAE 
gradually decreased toward the noise level, whereas CAP 
gradually improved during this time period, as mentioned 
above. CM, another indicator of hair cell function, exhibited 
essentially the same time course during the reperfusion pe-
riod as DPOAE [4]. Based on these findings, it is considered 
that the main lesion of cochlear reperfusion injury is in outer 
hair cells. In morphological studies of the cochlea, reperfu-
sion of the cochlea induces swelling of the outer hair cells 
and eventual rupture of the outer hair cell membrane and 
nucleus [4]. The swelling of terminals of afferent dendrites 
improved during the reperfusion period [4]. This morpho-
logical finding is in agreement with the fact that CAP gradu-
ally improved whereas DPOAE decreased during reperfu-
sion. Excitotoxicity during ischemia is involved in the swel-
ling of afferent neurons, which improved during reperfusion. 
It has been shown that the glutamate concentration in the 
perilymph, which increased during the ischemic period,   
decreased toward the pre-ischemia level upon reperfusion 
[10]. 
INVOLVEMENT OF REACTIVE OXYGEN SPECIES 
IN REPERFUSION INJURY OF THE COCHLEA 
  As described in a previous section, outer hair cells func-
tionally and structurally deteriorate during the early reperfu-
sion period. Recent studies have indicated that free radicals 
such as hydroxyl radicals and nitric oxide (NO) are involved 
in the injury of outer hair cells. 
  It has been generally accepted that reoxygenation causes 
the accumulation of superoxide anions in tissues. The super-
oxide anion is converted by superoxide dismutase to hydro-
gen peroxide, which is relatively unreactive toward most 
organic molecules. However, the hydroxyl radical, a potent 
oxidant capable of promoting oxidative damage, may be 
generated by the reaction of hydrogen peroxide with iron 
(Fenton reaction). Hydroxyl radicals can oxidize DNA, pro-
teins, and structural polymers including hyaluronic acid. In 
addition, they induce the peroxidation of polyunsaturated 
fatty acid, which damages biological membranes [30].   130    Current Neuropharmacology, 2010, Vol. 8, No. 2  Tabuchi et al. 
Hypoxia increased the iron concentration in the perilymph of 
the cochlea [31], and the marked production of hydroxyl 
radicals was demonstrated during the re-oxygenation phase 
after hypoxia [32]. These findings suggest that hydroxyl 
radicals were generated via the Fenton reaction during the 
early reperfusion period in cochlear ischemia-reperfusion 
injury. 
  Generally, the main source of superoxide anions during 
reperfusion is considered to be mitochondria. Reduced in-
termediates of mitochondrial electron transport systems ac-
cumulate during ischemia and are oxidized during reperfu-
sion (by reoxygenation), leading to the production of super-
oxide anions. Another potential source of superoxide anions 
is xanthine oxidase, which oxidizes hypoxanthine to xan-
thine and xanthine to urate. However, xanthine oxidase may 
not be involved in the generation of free radicals because 
allopurinol and oxypurinol, potent inhibitors of xanthine 
oxidase, did not exhibit any effect on cochlear ischemia-
reperfusion injury [33]. 
  Nitric oxide (NO) is also involved in the generation 
mechanism of cochlear ischemia-reperfusion injury. Tran-
sient ischemia causes a marked increase of NO production in 
the perilymph in the reperfusion period [34]. To date, three 
isoforms of NO synthase (NOS) have been distinguished: 
neuronal NOS (nNOS), endothelial NOS (eNOS), and induc-
ible NOS (iNOS). The constitutive isoforms of NOS (i.e., 
nNOS and eNOS), but not iNOS are expressed in the normal 
cochlea [35, 36]. Recent findings suggest that NO generated 
by nNOS and iNOS deteriorates the cochlea in ischemia-
reperfusion injury [29, 37, 38]. NO synthesized by iNOS 
plays a deleterious role in cerebral ischemia, and ischemia-
induced iNOS mRNA expression and iNOS activity were 
delayed by several hours (more than 6) after transient cere-
bral ischemia [39, 40]. The administration of aminogua-
nidine, an iNOS inhibitor, decreased the postischemic shift 
of the ABR or CAP threshold at 1 to 5 days after 60-minute 
ischemia, but not at 4 hours after ischemia [29, 38]. These 
results strongly suggest that NO generated by nNOS and by 
iNOS aggravates cochlear injury in early and late phases of 
reperfusion, respectively (Fig. 2).  
TIME THRESHOLD OF ISCHEMIA TO INDUCE 
COCHLEAR DYSFUNCTION 
  Individual tissues have quite variable oxygen require-
ments. For example, the brain cannot tolerate hypoxia for 
more than a few minutes without permanent injury, although 
skeletal muscles can tolerate severe hypoxia or ischemia for 
several hours [41]. Several researchers have examined the 
time threshold of ischemia to induce cochlear dysfunction 
using animal models. EP and other cochlear potentials start 
to decrease within a minute after the cochlea is subjected to 
ischemia. When circulation is resumed, cochlear functions 
fully recover if the ischemic period is less than 10 minutes. 
However, DPOAE significantly decreases after ischemia of 
10 minutes compared with the preischemic level [26]. CAP 
thresholds also elevate after ischemia of 10 minutes or longer 
[28]. These findings support the idea that ischemia of 10 
minutes or longer at least transiently elevates the hearing 
threshold. When cochlear functions are followed for long 
periods after the onset of recirculation, ischemia of 15 to 30 
minutes duration induces hair cell loss and permanent co-
chlear dysfunction [9, 29]. 
PHARMACOLOGICAL STRATEGIES TO PROTECT 
THE COCHLEA AGAINST ISCHEMIA-REPERFUS- 
ION INJURY 
  This section presents a brief overview of experimental 
data concerning pharmacological strategies for cochlear pro-
tection against ischemia-reperfusion injury. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Schematic view of cochlear ischemic injury. Glutamate is a putative neurotransmitter between inner hair cells and afferent neurons. 
Glutamate released from inner hair cells is promptly taken into the inner hair cells and supporting cells by glutamate transporters in the  
normal cochlea. Ischemia induces the excessive efflux of glutamate and dysfunction of the glutamate transporter. These cause the excitotox-
icity of afferent neurons. IHC: inner hair cell. OHCs: outer hair cells. Ischemia-Reperfusion Injury  Current Neuropharmacology, 2010, Vol. 8, No. 2    131 
1. Excitotoxicity 
  An AMPA/kainate receptor antagonist, 6-7-dinitro- 
quinoxaline-2,3-dione (DNQX), protected most radial den-
drites from ischemia-induced swelling [8]. In contrast to   
the protective effect of AMPA/kainate receptor inhibitors 
against cochlear excitotoxicity and cochlear ischemic injury, 
specific NMDA receptor antagonists including MK-801 and 
D-2-amino-5-phosphonopentanoate did not show any protec-
tive effect against cochlear ischemia [8, 23]. 
  There are several agents reported to reduce cochlear exci-
totoxicity including a GABA(A) agonist (muscimol [24]), 
dopamine [42, 43], riluzole [44], ebselen [45], and pituitary 
adenyl cyclase-activating polypeptide (PACAP) [46]. Be-
cause the excitotoxicity of cochlear afferent neurons often 
induces temporary hearing threshold shifts [24], these agents 
are potential therapeutic targets to prevent temporary hearing 
deterioration. 
  The majority of clinical trials of glutamatergic antago-
nists were conducted in the fields of stroke, traumatic brain 
injury and dementia. However, treatment with glutamatergic 
antagonists failed to obtain even modest beneficial results, 
and those clinical trials were interrupted [47]. In addition, the 
adverse effect profile of glutamatergic antagonists has been 
described. Based on the findings obtained in central nervous 
system disorders, it seems reasonable to consider local appli-
cation of glutamatergic antagonists for prevention of tempo-
rary elevation of hearing thresholds.  
2. Free Radical Scavengers and NOS Inhibitors 
  Seidman and Quirk [48] first demonstrated the involve-
ment of free radicals in cochlear ischemia-reperfusion injury. 
Since their report, several free radical scavengers have been 
reported to protect against cochlear ischemia-reperfusion 
injury, including U74006F, mannitol, edaravone, and di-
methylthiourea [4, 28, 48, 49]. 
  It has been suggested that superoxide and hydrogen per-
oxide have a limited reactivity with most biological mole-
cules in vivo, and their interaction in the presence of a transi-
tion metal (e.g., iron) forms far more reactive hydroxyl radi-
cals by the iron-catalyzed Haber-Weiss (Fenton) reaction 
that contribute to tissue injury [30]. The protective effects of 
deferoxamine, an iron chelator, in cochlear ischemia have 
been established [38, 50]. 
  In addition to free radical scavengers and iron chletors, 
NOS inhibitors protect the cochlea. N-nitro-L-arginine de-
creased the postischemic CAP threshold shift [28]. Inhibitors 
of nNOS (7-nitroindazole, 3-bromo-7-nitroindazole) and 
iNOS (aminoguanidine) also protect the cochlea against 
ischemia-reperfusion injury [29, 38, 50]. 
  Outer hair cells deteriorate during reperfusion, and co-
chlear reperfusion injury is most evidently observed in outer 
hair cells. DPOAE studies demonstrated that free radical 
scavengers, iron chelators, and NOS inhibitors protected 
outer hair cells from reperfusion injury [4, 50]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Schematic view of cochlear reperfusion injury. Reoxygenation leads to the generation of superoxide anions, in which mitochondrial 
dysfunction may be involved. Superoxide anions are converted into hydroxyl radicals via the Fenton reaction in the presence of iron. NO is 
also generated by nNOS and iNOS during the reperfusion period. These reactive oxygen species cause the reperfusion injury of outer hair 
cells. IHC: inner hair cell. OHCs: outer hair cells. 132    Current Neuropharmacology, 2010, Vol. 8, No. 2  Tabuchi et al. 
3. Adenosine Receptor Agonists 
  Although information on the cochlea is limited, several 
mechanisms have been proposed to account for the protec-
tive effects of A1 adenosine receptor agonists in nervous 
tissues. It is thought that deleterious Ca
2+ influx due to glu-
tamate excitotoxicity is a primary target for neuroprotective 
adenosine actions in the central nervous system [51-53]. The 
excitotoxicity of cochlear afferent dendrites induced by kai-
nic acid was attenuated by the application of 2-chloro-N6-
cyclopentyladenosine (CCPA), a highly selective adenosine 
A1 receptor agonist. Ford et al. [54] reported the effects of 
the round window application of R-PIA, a selective adeno-
sine A1 receptor agonist, on cochlear antioxidant enzymes, 
such as superoxide dismutase, glutathione peroxidase, and 
catalase. R-PIA elicited significant increases in the activity 
of these antioxidant enzymes and significantly reduced the 
levels of malondialdehyde, a marker of lipid peroxidation, 
generated in the cochlea. Namely, it is possible that adeno-
sine A1 receptor agonists protect the cochlea against ische-
mia-reperfusion injury by attenuating glutamate excitotoxic-
ity and through a radical scavenging effect. Indeed, CCPA 
attenuated cochlear injury induced by transient ischemia 
[55]. 
4. Growth Factors 
  Several authors have shown that growth factors like insu-
lin-like growth factor-1 (IGF-1), epidermal growth factor 
(EGF), and fibroblast growth factor may protect hair cells 
against damage triggered by ototoxic drugs or aging. These 
growth factors are important for the normal development and 
survival of cells including hair cells of the organ of Corti 
[56, 57]. Although the effects of growth factors on cochlear 
ischemia-reperfusion injury have not been fully elucidated, 
the protective effects of erythropoietin and IGF-1 have been 
reported [58, 59]. 
5. Steroids 
  Glucocorticoids have been widely used in the treatment 
of idiopathic sudden sensorineural hearing loss in humans. In 
a basic animal study, the cochlear function 4 hours after tran-
sient ischemia was significantly improved by glucocorti-
coids, prednisolone and methylprednisolone, at a relatively 
wide dose range in the case of pre-ischemic administration. 
On post-ischemic administration, higher doses of glucocorti-
coids were necessary to ameliorate cochlear ischemia-
reperfusion injury [54]. It is considered that glucocorticoids 
do not promote cochlear blood flow to protect hair cells [60, 
61], but directly protect outer hair cells [62]. 
  Dehydroepiandrosterone reportedly exhibits protective 
effects against cochlear ischemia-reperfusion injury [63]. 
Interestingly, dehydroepiandrosterone also protects hair cells 
against acoustic injury [64], suggesting that this steroid pro-
tects hair cells and the cochlea against other forms of co-
chlear injury. 
CONCLUSION 
  An understanding of the mechanisms of cochlear ische-
mia-reperfusion injury is mandatory for the development of 
therapeutic interventions directed toward this type of injury. 
When organs are rendered ischemic, there is a shift from 
aerobic to anaerobic metabolism, which results in a decrease 
in cellular ATP. Excitotoxicity induced by glutamate efflux 
and its failed removal from extracellular spaces during 
ischemia aggravates the ischemic injury of primary auditory 
neurons. Outer hair cells are the most vulnerable to cochlear 
reperfusion injury. Reactive oxygen species including hy-
droxyl radicals and NO are leading factors in the reperfusion 
injury of outer hair cells. Once recirculation is achieved after 
ischemia, efforts are needed to prevent cochlear injury in-
duced by reactive oxygen species and to minimize the loss of 
cochlear function. Many chemical agents including gluta-
mate receptor antagonists, free radical scavengers and NOS 
inhibitors, adenosine receptor agonists, and growth factors 
are under investigation. Further research will clarify the de-
tails of the pathogenesis of cochlear ischemia-reperfusion 
injuries, and efforts should be made to establish strategies to 
protect the cochlea. 
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